HEADER GLYCOSYLTRANSFERASE 09-AUG-94 1CXG OBSLTE 14-OCT-98 1CXG 2CXG TITLE X-RAY STRUCTURE OF CYCLODEXTRIN GLYCOSYLTRANSFERASE TITLE 2 COMPLEXED WITH ACARBOSE. IMPLICATIONS FOR THE CATALYTIC TITLE 3 MECHANISM OF GLYCOSIDASES COMPND MOL_ID: 1; COMPND 2 MOLECULE:; COMPND 3 CHAIN: NULL; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1 KEYWDS GLYCOSYLTRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR B.V.STROKOPYTOV,B.W.DIJKSTRA REVDAT 1 20-DEC-94 1CXG 0 JRNL AUTH B.STROKOPYTOV,D.PENNINGA,H.J.ROZEBOOM,K.H.KALK, JRNL AUTH 2 L.DIJKHUIZEN,B.W.DIJKSTRA JRNL TITL X-RAY STRUCTURE OF CYCLODEXTRIN JRNL TITL 2 GLYCOSYLTRANSFERASE COMPLEXED WITH ACARBOSE. JRNL TITL 3 IMPLICATIONS FOR THE CATALYTIC MECHANISM OF JRNL TITL 4 GLYCOSIDASES JRNL REF TO BE PUBLISHED JRNL REFN REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH C.L.L.LAWSON,R.VAN MONTFORT,B.STROKOPYTOV, REMARK 1 AUTH 2 H.J.ROZEBOOM,K.H.KALK,G.E.DE VRIES,D.PENNINGA, REMARK 1 AUTH 3 L.DIJKHUIZEN,B.W.DIJKSTRA REMARK 1 TITL NUCLEOTIDE SEQUENCE AND X-RAY STRUCTURE OF REMARK 1 TITL 2 CYCLODEXTRIN GLYCOSYLTRANSFERASE FROM BACILLUS REMARK 1 TITL 3 CIRCULANS STRAIN 251 IN A MALTOSE-DEPENDENT REMARK 1 TITL 4 CRYSTAL FORM REMARK 1 REF J.MOL.BIOL. V. 236 590 1994 REMARK 1 REFN ASTM JMOBAK UK ISSN 0022-2836 REMARK 1 REFERENCE 2 REMARK 1 AUTH C.L.L.LAWSON,J.BERGSMA,P.M.BRUINENBERG, REMARK 1 AUTH 2 G.E.DE VRIES,L.DIJKHUIZEN,B.W.DIJKSTRA REMARK 1 TITL MALTODEXTRIN-DEPENDENT CRYSTALLIZATION OF REMARK 1 TITL 2 CYCLOMALTODEXTRIN GLUCANOTRANSFERASE FROM BACILLUS REMARK 1 TITL 3 CIRCULANS REMARK 1 REF J.MOL.BIOL. V. 214 807 1990 REMARK 1 REFN ASTM JMOBAK UK ISSN 0022-2836 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT 1CXG REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 22281 REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD :NULL REMARK 3 FREE R VALUE TEST SET SELECTION :NULL REMARK 3 R VALUE (WORKING + TEST SET) :0.158 REMARK 3 R VALUE (WORKING SET) :NULL REMARK 3 FREE R VALUE :NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) :NULL REMARK 3 FREE R VALUE TEST SET COUNT :NULL REMARK 3 REMARK 3 USING ALL DATA, NO SIGMA CUTOFF. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5264 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 115 REMARK 3 SOLVENT ATOMS : 192 REMARK 3 REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : NULL ; NULL ; NULL REMARK 3 BOND ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TORSION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES (A) : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS (A) : NULL ; NULL ; NULL REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 RESTRAINT LIBRARIES. REMARK 3 STEREOCHEMISTRY : NULL REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1CXG COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 5 REMARK 5 1CXG SITE: CAT: CATALYTIC SITE. 1CXG SITE: CA1: 1ST CALCIUM REMARK 5 BINDING SITE. 1CXG SITE: CA2: 2ND CALCIUM BINDING SITE. REMARK 5 1CXG SITE: MB1: (MAL 689): FIRST MALTOSE-BINDING SITE. 1CXG REMARK 5 SITE: MB2: (MAL 690): 2ND MALTOSE-BINDING SITE. 1CXG SITE: REMARK 5 MB3: (MAL 688): 3RD MALTOSE-BINDING SITE. 1CXG NOTE: 1CXG REMARK 5 SITE MB1 ALSO CONTAINS RESIDUE SER 382 FROM A 1CXG SYMMETRY REMARK 5 -RELATED MOLECULE. SITE MB3 ALSO CONTAINS 1CXG RESIDUES SER REMARK 5 537, ALA 539, AND ASP 540 FROM 1CXG SYMMETRY-RELATED REMARK 5 MOLECULES. WATER MOLECULES ARE NOT 1CXG INCLUDED IN THESE REMARK 5 SITE RECORDS. FOR A DESCRIPTION 1CXG INCLUDING WATER REMARK 5 MOLECULES SEE PDB FILE 1CDG. 1CXG REMARK 6 REMARK 6 1CXG THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING REMARK 6 RESIDUES 1CXG HAVE VALUES WHICH DEVIATE FROM EXPECTED REMARK 6 VALUES BY MORE 1CXG THAN 4.0*RMSD (M=MODEL NUMBER; RES= REMARK 6 RESIDUE NAME; C=CHAIN 1CXG IDENTIFIER; SEQ=SEQUENCE NUMBER; REMARK 6 I=INSERTION CODE). 1CXG 1CXG COVALENT BOND LENGTHS: 1CXG M REMARK 6 RES C SEQI ATM1 ATM2 (FROM ENGH AND HUBER, 1991) 1CXG 0 PRO REMARK 6 149 C - O DIST. DEV. = 0.08 ANGSTROMS 1CXG 0 LYS 232 CE - REMARK 6 NZ DIST. DEV. = 0.07 ANGSTROMS 1CXG 0 ARG 284 CZ - NH2 REMARK 6 DIST. DEV. = 0.07 ANGSTROMS 1CXG 1CXG COVALENT BOND ANGLES: REMARK 6 1CXG M RES C SEQI ATM1 ATM2 ATM3 (FROM ENGH AND HUBER,1991) REMARK 6 1CXG 0 PHE 21 N - CA - C ANGL. DEV. = 10.4 DEGREES 1CXG 0 REMARK 6 GLY 51 N - CA - C ANGL. DEV. = 10.9 DEGREES 1CXG 0 ASP 135 REMARK 6 CB - CG - OD2 ANGL. DEV. = 10.1 DEGREES 1CXG 0 LEU 194 N - REMARK 6 CA - C ANGL. DEV. = 11.3 DEGREES 1CXG 0 LYS 216 CA - CB - REMARK 6 CG ANGL. DEV. = 10.5 DEGREES 1CXG 0 LYS 216 CG - CD - CE REMARK 6 ANGL. DEV. = 10.0 DEGREES 1CXG 0 GLY 222 N - CA - C ANGL. REMARK 6 DEV. = 11.3 DEGREES 1CXG 0 ARG 227 CB - CG - CD ANGL. DEV. REMARK 6 = 10.0 DEGREES 1CXG 0 ARG 284 CA - CB - CG ANGL. DEV. = REMARK 6 10.2 DEGREES 1CXG 0 ARG 331 NE - CZ - NH2 ANGL. DEV. = 10.9 REMARK 6 DEGREES 1CXG 0 GLY 407 N - CA - C ANGL. DEV. = 9.9 DEGREES REMARK 6 1CXG 0 ARG 412 CB - CG - CD ANGL. DEV. = 10.2 DEGREES 1CXG REMARK 6 0 GLY 532 N - CA - C ANGL. DEV. = 10.3 DEGREES 1CXG 0 GLU REMARK 6 545 N - CA - CB ANGL. DEV. = 9.8 DEGREES 1CXG 0 GLN 602 C - REMARK 6 CA - CB ANGL. DEV. = 10.0 DEGREES 1CXG 0 VAL 629 N - CA - C REMARK 6 ANGL. DEV. = 10.0 DEGREES 1CXG 0 HIS 668 N - CA - C ANGL. REMARK 6 DEV. = 10.2 DEGREES 1CXG REMARK 7 REMARK 7 1CXG ORIGINAL DEPOSITION REVISED PRIOR TO RELEASE 1CXG REMARK 7 TRACKING NUMBER: T5192, DATE RECEIVED: 18-NOV-94 1CXG REMARK 8 REMARK 8 1CXG THE SEQUENCE OF CGTASE OF THIS ENTRY HAS BEEN ENTERED REMARK 8 AS 1CXG X78145 BC251CGT IN THE EMBL SEQUENCE DATA BASE. IT REMARK 8 IS 1CXG REPORTED IN REFERENCE 1 ABOVE. 1CXG REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.75 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.98 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 1/2-X,-Y,1/2+Z REMARK 290 3555 -X,1/2+Y,1/2-Z REMARK 290 4555 1/2+X,1/2-Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 60.44350 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 32.87400 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 55.95150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 32.87400 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 60.44350 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 55.95150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 1 CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 SEQRES 1 686 ALA PRO ASP THR SER VAL SER ASN LYS GLN ASN PHE SER SEQRES 2 686 THR ASP VAL ILE TYR GLN ILE PHE THR ASP ARG PHE SER SEQRES 3 686 ASP GLY ASN PRO ALA ASN ASN PRO THR GLY ALA ALA PHE SEQRES 4 686 ASP GLY THR CYS THR ASN LEU ARG LEU TYR CYS GLY GLY SEQRES 5 686 ASP TRP GLN GLY ILE ILE ASN LYS ILE ASN ASP GLY TYR SEQRES 6 686 LEU THR GLY MET GLY VAL THR ALA ILE TRP ILE SER GLN SEQRES 7 686 PRO VAL GLU ASN ILE TYR SER ILE ILE ASN TYR SER GLY SEQRES 8 686 VAL ASN ASN THR ALA TYR HIS GLY TYR TRP ALA ARG ASP SEQRES 9 686 PHE LYS LYS THR ASN PRO ALA TYR GLY THR ILE ALA ASP SEQRES 10 686 PHE GLN ASN LEU ILE ALA ALA ALA HIS ALA LYS ASN ILE SEQRES 11 686 LYS VAL ILE ILE ASP PHE ALA PRO ASN HIS THR SER PRO SEQRES 12 686 ALA SER SER ASP GLN PRO SER PHE ALA GLU ASN GLY ARG SEQRES 13 686 LEU TYR ASP ASN GLY THR LEU LEU GLY GLY TYR THR ASN SEQRES 14 686 ASP THR GLN ASN LEU PHE HIS HIS ASN GLY GLY THR ASP SEQRES 15 686 PHE SER THR THR GLU ASN GLY ILE TYR LYS ASN LEU TYR SEQRES 16 686 ASP LEU ALA ASP LEU ASN HIS ASN ASN SER THR VAL ASP SEQRES 17 686 VAL TYR LEU LYS ASP ALA ILE LYS MET TRP LEU ASP LEU SEQRES 18 686 GLY ILE ASP GLY ILE ARG MET ASP ALA VAL LYS HIS MET SEQRES 19 686 PRO PHE GLY TRP GLN LYS SER PHE MET ALA ALA VAL ASN SEQRES 20 686 ASN TYR LYS PRO VAL PHE THR PHE GLY GLU TRP PHE LEU SEQRES 21 686 GLY VAL ASN GLU VAL SER PRO GLU ASN HIS LYS PHE ALA SEQRES 22 686 ASN GLU SER GLY MET SER LEU LEU ASP PHE ARG PHE ALA SEQRES 23 686 GLN LYS VAL ARG GLN VAL PHE ARG ASP ASN THR ASP ASN SEQRES 24 686 MET TYR GLY LEU LYS ALA MET LEU GLU GLY SER ALA ALA SEQRES 25 686 ASP TYR ALA GLN VAL ASP ASP GLN VAL THR PHE ILE ASP SEQRES 26 686 ASN HIS ASP MET GLU ARG PHE HIS ALA SER ASN ALA ASN SEQRES 27 686 ARG ARG LYS LEU GLU GLN ALA LEU ALA PHE THR LEU THR SEQRES 28 686 SER ARG GLY VAL PRO ALA ILE TYR TYR GLY THR GLU GLN SEQRES 29 686 TYR MET SER GLY GLY THR ASP PRO ASP ASN ARG ALA ARG SEQRES 30 686 ILE PRO SER PHE SER THR SER THR THR ALA TYR GLN VAL SEQRES 31 686 ILE GLN LYS LEU ALA PRO LEU ARG LYS CYS ASN PRO ALA SEQRES 32 686 ILE ALA TYR GLY SER THR GLN GLU ARG TRP ILE ASN ASN SEQRES 33 686 ASP VAL LEU ILE TYR GLU ARG LYS PHE GLY SER ASN VAL SEQRES 34 686 ALA VAL VAL ALA VAL ASN ARG ASN LEU ASN ALA PRO ALA SEQRES 35 686 SER ILE SER GLY LEU VAL THR SER LEU PRO GLN GLY SER SEQRES 36 686 TYR ASN ASP VAL LEU GLY GLY LEU LEU ASN GLY ASN THR SEQRES 37 686 LEU SER VAL GLY SER GLY GLY ALA ALA SER ASN PHE THR SEQRES 38 686 LEU ALA ALA GLY GLY THR ALA VAL TRP GLN TYR THR ALA SEQRES 39 686 ALA THR ALA THR PRO THR ILE GLY HIS VAL GLY PRO MET SEQRES 40 686 MET ALA LYS PRO GLY VAL THR ILE THR ILE ASP GLY ARG SEQRES 41 686 GLY PHE GLY SER SER LYS GLY THR VAL TYR PHE GLY THR SEQRES 42 686 THR ALA VAL SER GLY ALA ASP ILE THR SER TRP GLU ASP SEQRES 43 686 THR GLN ILE LYS VAL LYS ILE PRO ALA VAL ALA GLY GLY SEQRES 44 686 ASN TYR ASN ILE LYS VAL ALA ASN ALA ALA GLY THR ALA SEQRES 45 686 SER ASN VAL TYR ASP ASN PHE GLU VAL LEU SER GLY ASP SEQRES 46 686 GLN VAL SER VAL ARG PHE VAL VAL ASN ASN ALA THR THR SEQRES 47 686 ALA LEU GLY GLN ASN VAL TYR LEU THR GLY SER VAL SER SEQRES 48 686 GLU LEU GLY ASN TRP ASP PRO ALA LYS ALA ILE GLY PRO SEQRES 49 686 MET TYR ASN GLN VAL VAL TYR GLN TYR PRO ASN TRP TYR SEQRES 50 686 TYR ASP VAL SER VAL PRO ALA GLY LYS THR ILE GLU PHE SEQRES 51 686 LYS PHE LEU LYS LYS GLN GLY SER THR VAL THR TRP GLU SEQRES 52 686 GLY GLY SER ASN HIS THR PHE THR ALA PRO SER SER GLY SEQRES 53 686 THR ALA THR ILE ASN VAL ASN TRP GLN PRO FTNOTE 1 CIS PROLINE - PRO 372 FTNOTE 2 CIS PROLINE - PRO 506 FTNOTE 3 CIS PROLINE - PRO 624 FTNOTE 4 CIS PROLINE - PRO 634 HET MAL 688 23 HET MAL 689 23 HET MAL 692 23 HET ACR 693 44 HET CA 690 1 HET CA 691 1 HETNAM MAL MALTOSE HETNAM ACR ACARBOSE HETNAM CA CALCIUM ION HETSYN ACR 1,4-DEOXY-4-((5-HYDROXYMETHYL-2,3,4- HETSYN 2 ACR TRIHYDROXYCYCLOHEX-5,6-ENYL)AMINO)FRUCTOSE FORMUL 2 MAL 3(C12 H22 O11) FORMUL 5 ACR C25 H43 N O18 FORMUL 6 CA 2(CA 2+) FORMUL 8 HOH *192(H2 O1) HELIX 1 1 PHE 21 PHE 25 5 5 HELIX 2 2 ASN 29 ASN 33 5 5 HELIX 3 3 THR 35 PHE 39 5 5 HELIX 4 4 ASP 53 ASP 63 1 11 HELIX 5 5 GLY 64 MET 69 1 6 HELIX 6 6 THR 114 LYS 128 1 15 HELIX 7 7 THR 185 LYS 192 1 8 HELIX 8 8 ASN 204 LEU 221 1 18 HELIX 9 9 ALA 230 MET 234 5 5 HELIX 10 10 PRO 235 ASN 248 1 14 HELIX 11 11 SER 266 SER 276 1 11 HELIX 12 12 ASP 282 ARG 294 1 13 HELIX 13 13 ASN 299 TYR 314 1 16 HELIX 14 14 GLN 316 ASP 319 5 4 HELIX 15 15 ARG 339 SER 352 1 14 HELIX 16 16 PRO 372 ALA 376 5 5 HELIX 17 17 THR 385 ALA 395 1 11 HELIX 18 18 PRO 396 ASN 401 1 6 HELIX 19 19 ASN 401 GLY 407 1 7 HELIX 20 20 GLY 472 ALA 476 5 5 HELIX 21 21 SER 537 ALA 539 5 3 HELIX 22 22 VAL 610 GLY 614 5 5 HELIX 23 23 ASP 617 ALA 621 5 5 SHEET 1 A 8 SER 279 LEU 280 0 SHEET 2 A 8 PHE 253 GLY 256 1 N GLY 256 O SER 279 SHEET 3 A 8 GLY 225 MET 228 1 N ILE 226 O PHE 253 SHEET 4 A 8 LYS 131 PHE 136 1 N PHE 136 O ARG 227 SHEET 5 A 8 ALA 73 ILE 76 1 N ILE 74 O LYS 131 SHEET 6 A 8 ILE 17 ILE 20 1 N ILE 20 O TRP 75 SHEET 7 A 8 VAL 355 TYR 359 1 O ILE 358 N ILE 17 SHEET 8 A 8 VAL 321 THR 322 1 N THR 322 O ALA 357 SHEET 1 B 2 VAL 80 ASN 82 0 SHEET 2 B 2 ALA 102 THR 108 -1 O ARG 103 N GLU 81 SHEET 1 C 2 ILE 87 TYR 89 0 SHEET 2 C 2 VAL 92 ASN 94 -1 O VAL 92 N TYR 89 SHEET 1 D 2 HIS 140 PRO 143 0 SHEET 2 D 2 LEU 197 ASP 199 -1 O ALA 198 N SER 142 SHEET 1 E 2 LEU 157 ASP 159 0 SHEET 2 E 2 THR 162 GLY 165 -1 O THR 162 N ASP 159 SHEET 1 F 4 SER 408 ILE 414 0 SHEET 2 F 4 VAL 418 LYS 424 -1 O GLU 422 N GLN 410 SHEET 3 F 4 ASN 428 ASN 435 -1 O ALA 430 N ARG 423 SHEET 4 F 4 THR 487 THR 493 -1 O TYR 492 N VAL 429 SHEET 1 G 2 ALA 442 ILE 444 0 SHEET 2 G 2 PHE 480 LEU 482 -1 O LEU 482 N ALA 442 SHEET 1 H 2 GLY 454 TYR 456 0 SHEET 2 H 2 LEU 469 VAL 471 -1 O LEU 469 N TYR 456 SHEET 1 I 4 THR 500 GLY 505 0 SHEET 2 I 4 THR 514 ARG 520 -1 O ARG 520 N THR 500 SHEET 3 I 4 GLN 548 LYS 552 -1 O VAL 551 N ILE 515 SHEET 4 I 4 ILE 541 GLU 545 -1 N SER 543 O LYS 550 SHEET 1 J 5 MET 508 ALA 509 0 SHEET 2 J 5 TYR 576 VAL 581 1 O GLU 580 N ALA 509 SHEET 3 J 5 GLY 559 ALA 566 -1 N ILE 563 O TYR 576 SHEET 4 J 5 THR 528 PHE 531 -1 N TYR 530 O LYS 564 SHEET 5 J 5 THR 534 VAL 536 -1 O THR 534 N PHE 531 SHEET 1 K 3 TRP 636 PRO 643 0 SHEET 2 K 3 GLN 586 ASN 594 -1 N VAL 593 O TRP 636 SHEET 3 K 3 ALA 678 ASN 683 1 O ILE 680 N ARG 590 SHEET 1 L 3 ASN 603 GLY 608 0 SHEET 2 L 3 THR 647 GLN 656 -1 O LYS 651 N THR 607 SHEET 3 L 3 THR 659 TRP 662 -1 O THR 659 N GLN 656 SHEET 1 M 3 ASN 603 GLY 608 0 SHEET 2 M 3 THR 647 GLN 656 -1 O LYS 651 N THR 607 SHEET 3 M 3 HIS 668 THR 671 -1 O PHE 670 N ILE 648 SSBOND 1 CYS 43 CYS 50 CISPEP 1 ASP 371 PRO 372 0 0.38 CISPEP 2 GLY 505 PRO 506 0 -2.33 CISPEP 3 GLY 623 PRO 624 0 0.44 CISPEP 4 TYR 633 PRO 634 0 -0.15 SITE 1 CAT 3 ASP 229 GLU 257 ASP 328 SITE 1 CA1 6 ASP 27 ASN 29 ASN 32 ASN 33 SITE 2 CA1 6 GLY 51 ASP 53 SITE 1 CA2 4 ASN 139 ILE 190 ASP 199 HIS 233 SITE 1 MB1 5 TRP 616 LYS 651 TRP 662 GLU 663 SITE 2 MB1 5 ASN 667 SITE 1 MB2 7 THR 598 ALA 599 GLY 601 ASN 603 SITE 2 MB2 7 ASN 627 GLN 628 TYR 633 SITE 1 MB3 7 TYR 301 GLU 411 ARG 412 TRP 413 SITE 2 MB3 7 ILE 414 GLY 446 VAL 448 CRYST1 120.887 111.903 65.748 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008272 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008936 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015210 0.00000